
<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
      
      
        <link rel="canonical" href="https://biolink.github.io/biolink-model/CausalMechanismQualifierEnum/">
      
      
      
      
      <link rel="icon" href="../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.6.1, mkdocs-material-9.6.15">
    
    
      
        <title>Enum: CausalMechanismQualifierEnum - Biolink Model Documentation</title>
      
    
    
      <link rel="stylesheet" href="../assets/stylesheets/main.342714a4.min.css">
      
        
        <link rel="stylesheet" href="../assets/stylesheets/palette.06af60db.min.css">
      
      


    
    
      
    
    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../style.css">
    
    <script>__md_scope=new URL("..",location),__md_hash=e=>[...e].reduce(((e,_)=>(e<<5)-e+_.charCodeAt(0)),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      
  


  
  

<script id="__analytics">function __md_analytics(){function e(){dataLayer.push(arguments)}window.dataLayer=window.dataLayer||[],e("js",new Date),e("config","G-J23SCD6JB8"),document.addEventListener("DOMContentLoaded",(function(){document.forms.search&&document.forms.search.query.addEventListener("blur",(function(){this.value&&e("event","search",{search_term:this.value})}));document$.subscribe((function(){var t=document.forms.feedback;if(void 0!==t)for(var a of t.querySelectorAll("[type=submit]"))a.addEventListener("click",(function(a){a.preventDefault();var n=document.location.pathname,d=this.getAttribute("data-md-value");e("event","feedback",{page:n,data:d}),t.firstElementChild.disabled=!0;var r=t.querySelector(".md-feedback__note [data-md-value='"+d+"']");r&&(r.hidden=!1)})),t.hidden=!1})),location$.subscribe((function(t){e("config","G-J23SCD6JB8",{page_path:t.pathname})}))}));var t=document.createElement("script");t.async=!0,t.src="https://www.googletagmanager.com/gtag/js?id=G-J23SCD6JB8",document.getElementById("__analytics").insertAdjacentElement("afterEnd",t)}</script>
  
    <script>"undefined"!=typeof __md_analytics&&__md_analytics()</script>
  

    
    
    
  </head>
  
  
    
    
    
    
    
    <body dir="ltr" data-md-color-scheme="black" data-md-color-primary="black" data-md-color-accent="indigo">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
        
        <a href="#enum-causalmechanismqualifierenum" class="md-skip">
          Skip to content
        </a>
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

  

<header class="md-header md-header--shadow" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href=".." title="Biolink Model Documentation" class="md-header__button md-logo" aria-label="Biolink Model Documentation" data-md-component="logo">
      
  <img src="../images/biolink-logo.png" alt="logo">

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3zm0 5h18v2H3zm0 5h18v2H3z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Biolink Model Documentation
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Enum: CausalMechanismQualifierEnum
            
          </span>
        </div>
      </div>
    </div>
    
      
    
    
    
    
      
      
        <label class="md-header__button md-icon" for="__search">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        </label>
        <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12z"/></svg>
        </button>
      </nav>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" tabindex="0" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
      
    
    
      <div class="md-header__source">
        <a href="https://github.com/biolink/biolink-model" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512"><!--! Font Awesome Free 6.7.2 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc.--><path d="M439.55 236.05 244 40.45a28.87 28.87 0 0 0-40.81 0l-40.66 40.63 51.52 51.52c27.06-9.14 52.68 16.77 43.39 43.68l49.66 49.66c34.23-11.8 61.18 31 35.47 56.69-26.49 26.49-70.21-2.87-56-37.34L240.22 199v121.85c25.3 12.54 22.26 41.85 9.08 55a34.34 34.34 0 0 1-48.55 0c-17.57-17.6-11.07-46.91 11.25-56v-123c-20.8-8.51-24.6-30.74-18.64-45L142.57 101 8.45 235.14a28.86 28.86 0 0 0 0 40.81l195.61 195.6a28.86 28.86 0 0 0 40.8 0l194.69-194.69a28.86 28.86 0 0 0 0-40.81"/></svg>
  </div>
  <div class="md-source__repository">
    GitHub
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    



<nav class="md-nav md-nav--primary" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href=".." title="Biolink Model Documentation" class="md-nav__button md-logo" aria-label="Biolink Model Documentation" data-md-component="logo">
      
  <img src="../images/biolink-logo.png" alt="logo">

    </a>
    Biolink Model Documentation
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/biolink/biolink-model" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512"><!--! Font Awesome Free 6.7.2 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc.--><path d="M439.55 236.05 244 40.45a28.87 28.87 0 0 0-40.81 0l-40.66 40.63 51.52 51.52c27.06-9.14 52.68 16.77 43.39 43.68l49.66 49.66c34.23-11.8 61.18 31 35.47 56.69-26.49 26.49-70.21-2.87-56-37.34L240.22 199v121.85c25.3 12.54 22.26 41.85 9.08 55a34.34 34.34 0 0 1-48.55 0c-17.57-17.6-11.07-46.91 11.25-56v-123c-20.8-8.51-24.6-30.74-18.64-45L142.57 101 8.45 235.14a28.86 28.86 0 0 0 0 40.81l195.61 195.6a28.86 28.86 0 0 0 40.8 0l194.69-194.69a28.86 28.86 0 0 0 0-40.81"/></svg>
  </div>
  <div class="md-source__repository">
    GitHub
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href=".." class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    Overview
    
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../using-the-modeling-language/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    Using the LinkML Modeling Language
    
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../association-examples-with-qualifiers/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    Associations with Qualifiers
    
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../reading-a-qualifier-based-statement/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    Interpreting a Fully Qualified Edge
    
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../curating-the-model/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    Curating Biolink
    
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../maintaining-the-model/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    Maintaining Biolink
    
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../working-with-the-model/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    Working with Biolink
    
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="https://biolink.github.io/information-resource-registry" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    Infores Identifier Registry
    
  </span>
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_9" >
        
          
          <label class="md-nav__link" for="__nav_9" id="__nav_9_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    Visualizations
    
  </span>
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_9_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_9">
            <span class="md-nav__icon md-icon"></span>
            Visualizations
          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../categories.html" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    Classes (categories)
    
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../predicates.html" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    Predicates
    
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../qualifiers.html" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    Qualifiers
    
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../associations.html" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    Associations
    
  </span>
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../aspects.html" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    Aspects
    
  </span>
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../faq/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    FAQ
    
  </span>
  

      </a>
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#permissible-values" class="md-nav__link">
    <span class="md-ellipsis">
      Permissible Values
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#slots-constrained-by-this-enum" class="md-nav__link">
    <span class="md-ellipsis">
      Slots constrained by this enum
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#linkml-source" class="md-nav__link">
    <span class="md-ellipsis">
      LinkML Source
    </span>
  </a>
  
</li>
      
    </ul>
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              <article class="md-content__inner md-typeset">
                
                  


  
  


<h1 id="enum-causalmechanismqualifierenum"><strong> Enum: </strong> CausalMechanismQualifierEnum</h1>
<h2 id="permissible-values">Permissible Values</h2>
<table>
<thead>
<tr>
<th>Value</th>
<th>Meaning</th>
<th>Description</th>
</tr>
</thead>
<tbody>
<tr>
<td>modulation</td>
<td>None</td>
<td>A causal mechanism that effects the normal functioning of a protein in some way e.g., mixed agonist/antagonist or unclear whether action is positive or negative</td>
</tr>
<tr>
<td>allosteric_modulation</td>
<td>None</td>
<td>A modulation mechanism that occurs when a chemical exerts an effect on a protein targets via a different binding site than the natural ('orthosteric') ligand site.</td>
</tr>
<tr>
<td>mixed_allosteric_modulation</td>
<td>None</td>
<td>An allosteric modulation mechanism that occurs when a chemical may exert an activating effect or an inhibitory effect in different conditions / contexts (e.g. concentration, receptor conformational state, signaling pathway context, receptor subtype, cellular environment).</td>
</tr>
<tr>
<td>biphasic_allosteric_modulation</td>
<td>None</td>
<td>A mixed allosteric modulation mechanism that occurs when a chemical exerts an activating effect at lower concentrations, and an inhibitory effect at higher concentrations.</td>
</tr>
<tr>
<td>mixed_agonism</td>
<td>None</td>
<td>An modulation mechanism in which the effector acts as both an agonist (activating a receptor) and an antagonist (blocking a receptor) at different receptor sites.</td>
</tr>
<tr>
<td>positive_modulation</td>
<td>None</td>
<td>A modulation mechanism that positively effects the normal functioning of a target by increasing or enhancing its activity or abundance, or its sensitivity to other factors that do so.</td>
</tr>
<tr>
<td>potentiation</td>
<td>None</td>
<td>A positive modulation mechanism in which the effector binds to and enhances or intensifies the effect of some other chemical or drug on its target.</td>
</tr>
<tr>
<td>induction</td>
<td>None</td>
<td>A positive modulation mechanism in which the effector binds to and increases the activity/rate of an enzyme that processes drugs in the body.</td>
</tr>
<tr>
<td>cofactor</td>
<td>None</td>
<td>A positive modulation mechanism in which the effector (usually some non-protein chemical compound or metallic ion) is required for a target enzyme's biological/catalytic activity.</td>
</tr>
<tr>
<td>activation</td>
<td>None</td>
<td>A positive modulation mechanism in which the effector binds to and positively affects the normal functioning of its target.</td>
</tr>
<tr>
<td>positive_allosteric_modulation</td>
<td>None</td>
<td>A positive modulation mechanism in which the effector enhances the action of the endogenous ligand of a receptor by binding to a site distinct from that ligand (i.e. non-competitive inhibition)</td>
</tr>
<tr>
<td>agonism</td>
<td>None</td>
<td>An activation mechanism in which the effector binds and activates a receptor to mimic the effect of an endogenous ligand.</td>
</tr>
<tr>
<td>partial_agonism</td>
<td>None</td>
<td>An agonism mechanism in which the effector binds to and only partially activates a receptor (relative to the response to a full agonist)</td>
</tr>
<tr>
<td>biased_agonism</td>
<td>None</td>
<td>An agonism mechanism in which the effector  binds to a receptor and activates certain signaling pathways while ignoring others, allowing it to produce a desired effect without unwanted side effects.</td>
</tr>
<tr>
<td>antibody_agonism</td>
<td>None</td>
<td>An agonism mechanism in which the effector is an antobody that binds and activates a receptor to mimic the effect of an endogenous ligand.</td>
</tr>
<tr>
<td>molecular_channel_opening</td>
<td>None</td>
<td>An activation mechanism in which the effector binds to a molecular channel and facilitates transport of ions through it.</td>
</tr>
<tr>
<td>stimulation</td>
<td>None</td>
<td>An activation mechanism in which the effector directly or indirectly affects its target, stimulating a physiological response.</td>
</tr>
<tr>
<td>guanyl_nucleotide_exchange</td>
<td>None</td>
<td>An activation mechanism in which the effector catalyzes the exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) in a guanine nucleotide-binding protein (G-protein).</td>
</tr>
<tr>
<td>negative_modulation</td>
<td>None</td>
<td>A modulation mechanism that negatively effects the normal functioning of a target by decreasing or impeding its activity or abundance, or its sensitivity to other factors that do so.</td>
</tr>
<tr>
<td>negative_gene_editing_modulation</td>
<td>None</td>
<td>A negative modulation mechanism in which the effector elicits the negative modulation of its target through a gene editing activity.</td>
</tr>
<tr>
<td>gtpase_activation</td>
<td>None</td>
<td>An activation mechanism in which the effector accelerates the intrinsic GTPase activity of a G-protein, promoting the conversion of the active, GTP-bound form to the inactive, GDP-bound form, thereby terminating a signaling event. Note that this is a negative modulation mechanism because the target is the G-protein whose activity is attenuated through gtpase activation.</td>
</tr>
<tr>
<td>atpase_activation</td>
<td>None</td>
<td>An activation mechanism in which the effector accelerates the intrinsic ATPase activity of a target protein, promoting the conversion of the active, ATP-bound form to the inactive, ADP-bound form, thereby terminating a signaling event. Note that this is a negative modulation mechanism because the target is the protein whose activity is attenuated through atpase activation.</td>
</tr>
<tr>
<td>antisense_oligonucleotide_inhibition</td>
<td>None</td>
<td>A negative modulation mechanism in which an antisense oligonucleotide effector prevents translation of a complementary mRNA sequence through binding and targeting it for degradation. Note that while this is called "inhibition', it is not inhibition in the classic biochemical sense that requires a direct interaction between effector and target.</td>
</tr>
<tr>
<td>rna_interference_inhibition</td>
<td>None</td>
<td>A negative modulation mechanism in which an effector small interfering RNA (siRNA) molecule finds and destroys messenger RNA (mRNA) with a complementary sequence, preventing a specific gene from being translated into a protein. Note that while this is called "inhibition', it is not inhibition in the classic biochemical sense that requires a direct interaction between effector and target.</td>
</tr>
<tr>
<td>suppression</td>
<td>None</td>
<td>A negative modulation mechanism in which the effector directly or indirectly affects its target, suppressing a physiological process.</td>
</tr>
<tr>
<td>feedback_inhibition</td>
<td>None</td>
<td>An negative modulation mechanism in which the end product of a metabolic pathway inhibits an enzyme early in that same pathway, which stops the production of the final product when it's no longer needed.</td>
</tr>
<tr>
<td>inhibition</td>
<td>None</td>
<td>A negative modulation mechanism in which the effector binds to the target and negatively effects its normal function, e.g. prevention of enzymatic reaction or activation of downstream pathway.</td>
</tr>
<tr>
<td>antibody_inhibition</td>
<td>None</td>
<td>An inhibition mechanism in which an antibody effector specifically binds to and interferes with the target.</td>
</tr>
<tr>
<td>antagonism</td>
<td>None</td>
<td>An inhibition mechanism in which the effector binds to a receptor and prevents activation by an agonist through competing for the binding site.</td>
</tr>
<tr>
<td>allosteric_antagonism</td>
<td>None</td>
<td>An inhibition mechanism in which the effector binds to a receptor at an allosteric site and prevents activation by a positive allosteric modulator at that site.</td>
</tr>
<tr>
<td>non_competitive_antagonism</td>
<td>None</td>
<td>An inhibition mechanism in which the effector binds a site distinct from the agonist's binding site (non-orthosteric), or irreversibly/insurmountably inactivates the receptor - reduces the receptor’s maximal response (Emax) in a way that cannot be overcome by adding more agonist.</td>
</tr>
<tr>
<td>competitive_inhibition</td>
<td>None</td>
<td>An inhibition mechanism in which the effector binds to a target molecule (such as an enzyme) and prevents the binding of a substrate (or another binding partner) and vice versa.</td>
</tr>
<tr>
<td>noncompetitive_inhibition</td>
<td>None</td>
<td>An inhibition mechanism in which the effector binds to a target molecule (such as an enzyme) at a site other than the active site, in a way that reduces the activity of the target.</td>
</tr>
<tr>
<td>negative_allosteric_modulation</td>
<td>None</td>
<td>A noncompetitive inhibition mechanism in which the effector reduces or prevents the action of the endogenous ligand of a receptor by binding to a site distinct from that ligand, and causing a conformational change that affects ligand binding.</td>
</tr>
<tr>
<td>gating_inhibition</td>
<td>None</td>
<td>An inhibition mechanism mediated by the transition of ion channels between their open (conducting) and closed (non-conducting) conformational states.</td>
</tr>
<tr>
<td>irreversible_inhibition</td>
<td>None</td>
<td>An inhibition mechanism in which an effector permanently binds to a target, permanently disrupting its activity.</td>
</tr>
<tr>
<td>molecular_channel_blockage</td>
<td>None</td>
<td>An inhibition mechanism in which the effector binds to a molecular channel and prevents or reduces transport of ions through it.</td>
</tr>
<tr>
<td>inverse_agonism</td>
<td>None</td>
<td>An inhibition mechanism in which the effector binds to the same receptor-binding site as an agonist and antagonizes its effects, often exerting the opposite effect of the agonist by suppressing spontaneous receptor signaling.</td>
</tr>
<tr>
<td>binding</td>
<td>None</td>
<td>A modulation mechanism mediated by the direct contact between effector and target chemical or biomolecular entity, which form a stable physical interaction (typically non-covalent).</td>
</tr>
<tr>
<td>covalent_binding</td>
<td>None</td>
<td>A modulation mechanism mediated by a direct covalent binding interaction between effector and target chemical or biomolecular entity.</td>
</tr>
<tr>
<td>adduction</td>
<td>None</td>
<td>A covalent binding mechanism in which a drug-protein adduct forms by the covalent binding of electrophilic drugs or their reactive metabolite(s) to a target protein.</td>
</tr>
<tr>
<td>crosslinking</td>
<td>None</td>
<td>A covalent binding mechanism in which an effector induces cross-linking of target proteins or nucleic acids - covalently joining them into a rigid structure.</td>
</tr>
<tr>
<td>transglutamination</td>
<td>None</td>
<td>A covalent binding mechanism involving formation of a covalent bond between a glutamine residue and an amine as catalyzed by a transglutaminase.</td>
</tr>
<tr>
<td>disuphide_binding</td>
<td>None</td>
<td>A covalent binding mechanism involving a covalent bond formed between two cysteine residues in or between proteins.</td>
</tr>
<tr>
<td>stabilization</td>
<td>None</td>
<td>A modulation mechanism in which the effector increases the conformational stability of a protein or complex.</td>
</tr>
<tr>
<td>chaperone_mediated_stabilization</td>
<td>None</td>
<td></td>
</tr>
<tr>
<td>destabilization</td>
<td>None</td>
<td>A modulation mechanism in which a chaperone molecule directly binds to a partially folded biosynthetic intermediate to stabilize the protein and allow it to complete the folding process to yield a functional protein.</td>
</tr>
<tr>
<td>degradation</td>
<td>None</td>
<td>A modulation mechanism that controls protein and cellular component levels through the regulated breakdown and recycling of molecules.</td>
</tr>
<tr>
<td>cleavage</td>
<td>None</td>
<td>A modulation mechanism in which an effector promotes degeneration of the target protein through cleaving of the peptide bonds.</td>
</tr>
<tr>
<td>hydrolysis</td>
<td>None</td>
<td>A modulation mechanism in which an effector cleaves its target through a chemical reaction where a molecule of water is used to break a bond.</td>
</tr>
<tr>
<td>disruption</td>
<td>None</td>
<td>A modulation mechanism in which an effector destabilizes or disrupts a protein complex, macromolecular assembly, cell membrane etc.</td>
</tr>
<tr>
<td>opening</td>
<td>None</td>
<td>A modulation mechanism in which an effector positively effects the normal functioning of an ion channel e.g., facilitates transport of ions through the channel.</td>
</tr>
<tr>
<td>multitarget_modulation</td>
<td>None</td>
<td>A modulation mechanism in which an effector achieves a physiological effect through simultaneous interaction with multiple gene targets.</td>
</tr>
<tr>
<td>chelation</td>
<td>None</td>
<td>A modulation mechanism in which an effector binds to a metal ion target, reducing its availability/reactivity for further interactions.</td>
</tr>
<tr>
<td>release</td>
<td>None</td>
<td>A modulation mechanism in which an effector reverses the normal functioning of a transporter, causing release of the substrate, rather than uptake</td>
</tr>
<tr>
<td>sequestration</td>
<td>None</td>
<td>A modulation mechanism in which an effector binds to a substance such as a drug, toxin or metabolite and reduces its availability for further interactions.</td>
</tr>
<tr>
<td>oxidoreduction</td>
<td>None</td>
<td>A modulation mechanism in which in which electrons are transferred between molecules catalyzed by an oxidoreductase enzyme.</td>
</tr>
<tr>
<td>exogenous_protein</td>
<td>None</td>
<td>A modulation mechanism in which a protein from an exogenous source acts as a substitute or supplement for a specific protein which is absent or has reduced function in an affected target/subject.</td>
</tr>
<tr>
<td>exogenous_gene</td>
<td>None</td>
<td>A modulation mechanism in which a nucleic acid from an exogenous source acts as a substitute or supplement for a specific gene which is absent or has reduced function in an affected target/subject.</td>
</tr>
<tr>
<td>transcriptional_regulation</td>
<td>None</td>
<td>A modulation mechanism mediated by through the control of target gene transcription.</td>
</tr>
<tr>
<td>translational_regulation</td>
<td>None</td>
<td>A modulation mechanism mediated by through the control of target gene translation.</td>
</tr>
<tr>
<td>catalytic_activity</td>
<td>None</td>
<td>A modulation mechanism mediated by through the catalytic activity of the effector on the target.</td>
</tr>
<tr>
<td>chemical_modification</td>
<td>None</td>
<td>A modulation mechanism mediated by a protein/complex effector altering a small molecule by modifying it or converting it to something else.</td>
</tr>
<tr>
<td>relocalization</td>
<td>None</td>
<td>A modulation mechanism mediated by an effector that alters the localization of a target in the cell or body.</td>
</tr>
<tr>
<td>isomerization</td>
<td>None</td>
<td>A modulation mechanism mediated by an effector that alters the isomeric conformation of a target.</td>
</tr>
<tr>
<td>signaling_mediated_control</td>
<td>None</td>
<td>A modulation mechanism mediated by the activation or control of signaling events that influence the some aspect of the target entity (e.g. its activity, processing, transport, etc.).</td>
</tr>
<tr>
<td>immune_system_modulation</td>
<td>None</td>
<td>A modulation mechanism in which the actions of the effector on the immune system ultimately mediate the affects a target.</td>
</tr>
<tr>
<td>vaccine_antigen</td>
<td>None</td>
<td>An immune system modulation mechanism in which a vaccine mediates its effect through the activation of the immune system against the target.</td>
</tr>
<tr>
<td>post_transcriptional_regulation</td>
<td>None</td>
<td>A modulation mechanism which controls expression of a target gene at the RNA level after a gene has been transcribed into messenger RNA (mRNA).</td>
</tr>
<tr>
<td>molecular_modification</td>
<td>None</td>
<td>A modulation mechanism through which an effect is mediated by the modification of a target, through addition of chemical moieties such phosphate groups, ubiquitin, lipids, etc., which alter its activity or cellular behavior.</td>
</tr>
<tr>
<td>phosphorylation</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>dephosphorylation</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>neddylation</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>deneddylation</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>lipidation</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>palmitoylation</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>myristoylation</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>tyrosination</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>carboxylation</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>ubiquitination</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>monoubiquitination</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>polyubiquitination</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>deubiquitination</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>sulfation</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>reduction</td>
<td>None</td>
<td>A molecular modification mechanism in which an effector modifies a target substrate via a reduction reaction.</td>
</tr>
<tr>
<td>oxidation</td>
<td>None</td>
<td>A molecular modification mechanism in which an effector modifies a target substrate via an oxidation reaction.</td>
</tr>
<tr>
<td>acetylation</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>deacetylation</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>glycosylation</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>deglycosylation</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>methylation</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>trimethylation</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>demethylation</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>sumoylation</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>desumoylation</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>ADP-ribosylation</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>de-ADP-ribosylation</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>ampylation</td>
<td>None</td>
<td>A molecular modification involving the addition of an adenylyl (AMP) moiety to a substrate protein residue.</td>
</tr>
<tr>
<td>hydroxylation</td>
<td>None</td>
<td>None</td>
</tr>
<tr>
<td>s_nitrosylation</td>
<td>None</td>
<td>None</td>
</tr>
</tbody>
</table>
<h2 id="slots-constrained-by-this-enum">Slots constrained by this enum</h2>
<table>
<thead>
<tr>
<th>Name</th>
</tr>
</thead>
<tbody>
<tr>
<td><a href="../causal_mechanism_qualifier/">causal_mechanism_qualifier</a></td>
</tr>
<tr>
<td><a href="../causal_mechanism_qualifier/">causal_mechanism_qualifier</a></td>
</tr>
</tbody>
</table>
<h2 id="linkml-source">LinkML Source</h2>
<details open>

<pre><code class="language-yaml">name: CausalMechanismQualifierEnum
from_schema: https://w3id.org/biolink/vocab/
permissible_values:
  modulation:
    text: modulation
    description: A causal mechanism that effects the normal functioning of a protein
      in some way e.g., mixed agonist/antagonist or unclear whether action is positive
      or negative
  allosteric_modulation:
    text: allosteric_modulation
    description: A modulation mechanism that occurs when a chemical exerts an effect
      on a protein targets via a different binding site than the natural ('orthosteric')
      ligand site.
    is_a: modulation
  mixed_allosteric_modulation:
    text: mixed_allosteric_modulation
    description: An allosteric modulation mechanism that occurs when a chemical may
      exert an activating effect or an inhibitory effect in different conditions /
      contexts (e.g. concentration, receptor conformational state, signaling pathway
      context, receptor subtype, cellular environment).
    is_a: allosteric_modulation
  biphasic_allosteric_modulation:
    text: biphasic_allosteric_modulation
    description: A mixed allosteric modulation mechanism that occurs when a chemical
      exerts an activating effect at lower concentrations, and an inhibitory effect
      at higher concentrations.
    is_a: mixed_allosteric_modulation
  mixed_agonism:
    text: mixed_agonism
    description: An modulation mechanism in which the effector acts as both an agonist
      (activating a receptor) and an antagonist (blocking a receptor) at different
      receptor sites.
    is_a: modulation
  positive_modulation:
    text: positive_modulation
    description: A modulation mechanism that positively effects the normal functioning
      of a target by increasing or enhancing its activity or abundance, or its sensitivity
      to other factors that do so.
    is_a: modulation
  potentiation:
    text: potentiation
    description: A positive modulation mechanism in which the effector binds to and
      enhances or intensifies the effect of some other chemical or drug on its target.
    is_a: positive_modulation
  induction:
    text: induction
    description: A positive modulation mechanism in which the effector binds to and
      increases the activity/rate of an enzyme that processes drugs in the body.
    is_a: positive_modulation
    close_mappings:
    - DGIdb:inducer
  cofactor:
    text: cofactor
    description: A positive modulation mechanism in which the effector (usually some
      non-protein chemical compound or metallic ion) is required for a target enzyme's
      biological/catalytic activity.
    is_a: positive_modulation
  activation:
    text: activation
    description: A positive modulation mechanism in which the effector binds to and
      positively affects the normal functioning of its target.
    is_a: positive_modulation
    close_mappings:
    - CHEMBL.MECHANISM:activator
    - DGIdb:activator
  positive_allosteric_modulation:
    text: positive_allosteric_modulation
    description: A positive modulation mechanism in which the effector enhances the
      action of the endogenous ligand of a receptor by binding to a site distinct
      from that ligand (i.e. non-competitive inhibition)
    is_a: activation
    close_mappings:
    - CHEMBL.MECHANISM:positive_allosteric_modulator
    - CHEMBL.MECHANISM:positive_modulator
    - DGIdb:positive_allosteric_modulator
    broad_mappings:
    - DGIdb:modulator
    - DGIdb:allosteric_modulator
  agonism:
    text: agonism
    description: An activation mechanism in which the effector binds and activates
      a receptor to mimic the effect of an endogenous ligand.
    is_a: activation
    close_mappings:
    - CHEMBL.MECHANISM:agonist
    - DGIdb:agonist
    narrow_mappings:
    - CHEMBL.MECHANISM:partial_agonist
    - DGIdb:partial_agonist
  partial_agonism:
    text: partial_agonism
    description: An agonism mechanism in which the effector binds to and only partially
      activates a receptor (relative to the response to a full agonist)
    is_a: agonism
  biased_agonism:
    text: biased_agonism
    description: An agonism mechanism in which the effector  binds to a receptor and
      activates certain signaling pathways while ignoring others, allowing it to produce
      a desired effect without unwanted side effects.
    is_a: agonism
  antibody_agonism:
    text: antibody_agonism
    description: An agonism mechanism in which the effector is an antobody that binds
      and activates a receptor to mimic the effect of an endogenous ligand.
    is_a: agonism
  molecular_channel_opening:
    text: molecular_channel_opening
    description: An activation mechanism in which the effector binds to a molecular
      channel and facilitates transport of ions through it.
    is_a: activation
    close_mappings:
    - CHEMBL.MECHANISM:opener
  stimulation:
    text: stimulation
    description: An activation mechanism in which the effector directly or indirectly
      affects its target, stimulating a physiological response.
    is_a: activation
    close_mappings:
    - DGIdb:stimulator
    - SEMMEDDB:STIMULATES
    - DGIdb:stimulator
  guanyl_nucleotide_exchange:
    text: guanyl_nucleotide_exchange
    description: An activation mechanism in which the effector catalyzes the exchange
      of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) in a guanine
      nucleotide-binding protein (G-protein).
    is_a: activation
  negative_modulation:
    text: negative_modulation
    description: A modulation mechanism that negatively effects the normal functioning
      of a target by decreasing or impeding its activity or abundance, or its sensitivity
      to other factors that do so.
    is_a: modulation
    narrow_mappings:
    - DGIdb:negative_modulator
  negative_gene_editing_modulation:
    text: negative_gene_editing_modulation
    description: A negative modulation mechanism in which the effector elicits the
      negative modulation of its target through a gene editing activity.
    is_a: negative_modulation
  gtpase_activation:
    text: gtpase_activation
    description: An activation mechanism in which the effector accelerates the intrinsic
      GTPase activity of a G-protein, promoting the conversion of the active, GTP-bound
      form to the inactive, GDP-bound form, thereby terminating a signaling event.
      Note that this is a negative modulation mechanism because the target is the
      G-protein whose activity is attenuated through gtpase activation.
    is_a: negative_modulation
  atpase_activation:
    text: atpase_activation
    description: An activation mechanism in which the effector accelerates the intrinsic
      ATPase activity of a target protein, promoting the conversion of the active,
      ATP-bound form to the inactive, ADP-bound form, thereby terminating a signaling
      event. Note that this is a negative modulation mechanism because the target
      is the protein whose activity is attenuated through atpase activation.
    is_a: negative_modulation
  antisense_oligonucleotide_inhibition:
    text: antisense_oligonucleotide_inhibition
    description: A negative modulation mechanism in which an antisense oligonucleotide
      effector prevents translation of a complementary mRNA sequence through binding
      and targeting it for degradation. Note that while this is called &quot;inhibition',
      it is not inhibition in the classic biochemical sense that requires a direct
      interaction between effector and target.
    is_a: negative_modulation
  rna_interference_inhibition:
    text: rna_interference_inhibition
    description: A negative modulation mechanism in which an effector small interfering
      RNA (siRNA) molecule finds and destroys messenger RNA (mRNA) with a complementary
      sequence, preventing a specific gene from being translated into a protein. Note
      that while this is called &quot;inhibition', it is not inhibition in the classic
      biochemical sense that requires a direct interaction between effector and target.
    is_a: negative_modulation
  suppression:
    text: suppression
    description: A negative modulation mechanism in which the effector directly or
      indirectly affects its target, suppressing a physiological process.
    is_a: negative_modulation
  feedback_inhibition:
    text: feedback_inhibition
    description: An negative modulation mechanism in which the end product of a metabolic
      pathway inhibits an enzyme early in that same pathway, which stops the production
      of the final product when it's no longer needed.
    is_a: negative_modulation
  inhibition:
    text: inhibition
    description: A negative modulation mechanism in which the effector binds to the
      target and negatively effects its normal function, e.g. prevention of enzymatic
      reaction or activation of downstream pathway.
    is_a: negative_modulation
    close_mappings:
    - DGIdb:inhibitor
    - SEMMEDDB:INHIBITS
    narrow_mappings:
    - DGIdb:blocker
    - DGIdb:channel_blocker
    - DGIdb:gating_inhibitor
    - CHEMBL.MECHANISM:antisense_inhibitor
    - CHEMBL.MECHANISM:blocker
    - CHEMBL.MECHANISM:inhibitor
    - CHEMBL.MECHANISM:negative_allosteric_modulator
    - CHEMBL.MECHANISM:negative_modulator
    - DGIdb:negative_modulator
  antibody_inhibition:
    text: antibody_inhibition
    description: An inhibition mechanism in which an antibody effector specifically
      binds to and interferes with the target.
    is_a: inhibition
  antagonism:
    text: antagonism
    description: An inhibition mechanism in which the effector binds to a receptor
      and prevents activation by an agonist through competing for the binding site.
    is_a: inhibition
    close_mappings:
    - DGIdb:antagonist
    - CHEMBL.MECHANISM:antagonist
    narrow_mappings:
    - CHEMBL.MECHANISM:allosteric_antagonist
  allosteric_antagonism:
    text: allosteric_antagonism
    description: An inhibition mechanism in which the effector binds to a receptor
      at an allosteric site and prevents activation by a positive allosteric modulator
      at that site.
    is_a: antagonism
  non_competitive_antagonism:
    text: non_competitive_antagonism
    description: An inhibition mechanism in which the effector binds a site distinct
      from the agonist's binding site (non-orthosteric), or irreversibly/insurmountably
      inactivates the receptor - reduces the receptor’s maximal response (Emax) in
      a way that cannot be overcome by adding more agonist.
    is_a: antagonism
  competitive_inhibition:
    text: competitive_inhibition
    description: An inhibition mechanism in which the effector binds to a target molecule
      (such as an enzyme) and prevents the binding of a substrate (or another binding
      partner) and vice versa.
    is_a: inhibition
  noncompetitive_inhibition:
    text: noncompetitive_inhibition
    description: An inhibition mechanism in which the effector binds to a target molecule
      (such as an enzyme) at a site other than the active site, in a way that reduces
      the activity of the target.
    is_a: inhibition
  negative_allosteric_modulation:
    text: negative_allosteric_modulation
    description: A noncompetitive inhibition mechanism in which the effector reduces
      or prevents the action of the endogenous ligand of a receptor by binding to
      a site distinct from that ligand, and causing a conformational change that affects
      ligand binding.
    is_a: noncompetitive_inhibition
    close_mappings:
    - CHEMBL.MECHANISM:negative_allosteric_modulator
    - DGIdb:inhibitory_allosteric_modulator
  gating_inhibition:
    text: gating_inhibition
    description: An inhibition mechanism mediated by the transition of ion channels
      between their open (conducting) and closed (non-conducting) conformational states.
    is_a: inhibition
  irreversible_inhibition:
    text: irreversible_inhibition
    description: An inhibition mechanism in which an effector permanently binds to
      a target, permanently disrupting its activity.
    is_a: inhibition
  molecular_channel_blockage:
    text: molecular_channel_blockage
    description: An inhibition mechanism in which the effector binds to a molecular
      channel and prevents or reduces transport of ions through it.
    is_a: inhibition
  inverse_agonism:
    text: inverse_agonism
    description: An inhibition mechanism in which the effector binds to the same receptor-binding
      site as an agonist and antagonizes its effects, often exerting the opposite
      effect of the agonist by suppressing spontaneous receptor signaling.
    is_a: inhibition
    close_mappings:
    - CHEMBL.MECHANISM:inverse_agonist
    - DGIdb:inverse_agonist
  binding:
    text: binding
    description: A modulation mechanism mediated by the direct contact between effector
      and target chemical or biomolecular entity, which form a stable physical interaction
      (typically non-covalent).
    is_a: modulation
  covalent_binding:
    text: covalent_binding
    description: A modulation mechanism mediated by a direct covalent binding interaction
      between effector and target chemical or biomolecular entity.
    is_a: modulation
  adduction:
    text: adduction
    description: A covalent binding mechanism in which a drug-protein adduct forms
      by the covalent binding of electrophilic drugs or their reactive metabolite(s)
      to a target protein.
    is_a: covalent_binding
  crosslinking:
    text: crosslinking
    description: A covalent binding mechanism in which an effector induces cross-linking
      of target proteins or nucleic acids - covalently joining them into a rigid structure.
    is_a: covalent_binding
  transglutamination:
    text: transglutamination
    description: A covalent binding mechanism involving formation of a covalent bond
      between a glutamine residue and an amine as catalyzed by a transglutaminase.
    is_a: covalent_binding
  disuphide_binding:
    text: disuphide_binding
    description: A covalent binding mechanism involving a covalent bond formed between
      two cysteine residues in or between proteins.
    is_a: covalent_binding
  stabilization:
    text: stabilization
    description: A modulation mechanism in which the effector increases the conformational
      stability of a protein or complex.
    is_a: modulation
    close_mappings:
    - CHEMBL.MECHANISM:stabiliser
  chaperone_mediated_stabilization:
    text: chaperone_mediated_stabilization
    description: ''
    is_a: stabilization
  destabilization:
    text: destabilization
    description: A modulation mechanism in which a chaperone molecule directly binds
      to a partially folded biosynthetic intermediate to stabilize the protein and
      allow it to complete the folding process to yield a functional protein.
    is_a: modulation
  degradation:
    text: degradation
    description: A modulation mechanism that controls protein and cellular component
      levels through the regulated breakdown and recycling of molecules.
    is_a: modulation
  cleavage:
    text: cleavage
    description: A modulation mechanism in which an effector promotes degeneration
      of the target protein through cleaving of the peptide bonds.
    is_a: modulation
  hydrolysis:
    text: hydrolysis
    description: A modulation mechanism in which an effector cleaves its target through
      a chemical reaction where a molecule of water is used to break a bond.
    is_a: modulation
  disruption:
    text: disruption
    description: A modulation mechanism in which an effector destabilizes or disrupts
      a protein complex, macromolecular assembly, cell membrane etc.
    is_a: modulation
  opening:
    text: opening
    description: A modulation mechanism in which an effector positively effects the
      normal functioning of an ion channel e.g., facilitates transport of ions through
      the channel.
    is_a: modulation
  multitarget_modulation:
    text: multitarget_modulation
    description: A modulation mechanism in which an effector achieves a physiological
      effect through simultaneous interaction with multiple gene targets.
    is_a: modulation
  chelation:
    text: chelation
    description: A modulation mechanism in which an effector binds to a metal ion
      target, reducing its availability/reactivity for further interactions.
    is_a: modulation
  release:
    text: release
    description: A modulation mechanism in which an effector reverses the normal functioning
      of a transporter, causing release of the substrate, rather than uptake
    is_a: modulation
    close_mappings:
    - CHEMBL:MECHANISM:releasing_agent
  sequestration:
    text: sequestration
    description: A modulation mechanism in which an effector binds to a substance
      such as a drug, toxin or metabolite and reduces its availability for further
      interactions.
    is_a: modulation
  oxidoreduction:
    text: oxidoreduction
    description: A modulation mechanism in which in which electrons are transferred
      between molecules catalyzed by an oxidoreductase enzyme.
    is_a: modulation
  exogenous_protein:
    text: exogenous_protein
    description: A modulation mechanism in which a protein from an exogenous source
      acts as a substitute or supplement for a specific protein which is absent or
      has reduced function in an affected target/subject.
    is_a: modulation
  exogenous_gene:
    text: exogenous_gene
    description: A modulation mechanism in which a nucleic acid from an exogenous
      source acts as a substitute or supplement for a specific gene which is absent
      or has reduced function in an affected target/subject.
    is_a: modulation
  transcriptional_regulation:
    text: transcriptional_regulation
    description: A modulation mechanism mediated by through the control of target
      gene transcription.
    is_a: modulation
  translational_regulation:
    text: translational_regulation
    description: A modulation mechanism mediated by through the control of target
      gene translation.
    is_a: modulation
  catalytic_activity:
    text: catalytic_activity
    description: A modulation mechanism mediated by through the catalytic activity
      of the effector on the target.
    is_a: modulation
  chemical_modification:
    text: chemical_modification
    description: A modulation mechanism mediated by a protein/complex effector altering
      a small molecule by modifying it or converting it to something else.
    is_a: modulation
  relocalization:
    text: relocalization
    description: A modulation mechanism mediated by an effector that alters the localization
      of a target in the cell or body.
    is_a: modulation
  isomerization:
    text: isomerization
    description: A modulation mechanism mediated by an effector that alters the isomeric
      conformation of a target.
    is_a: modulation
  signaling_mediated_control:
    text: signaling_mediated_control
    description: A modulation mechanism mediated by the activation or control of signaling
      events that influence the some aspect of the target entity (e.g. its activity,
      processing, transport, etc.).
    is_a: modulation
  immune_system_modulation:
    text: immune_system_modulation
    description: A modulation mechanism in which the actions of the effector on the
      immune system ultimately mediate the affects a target.
    is_a: modulation
  vaccine_antigen:
    text: vaccine_antigen
    description: An immune system modulation mechanism in which a vaccine mediates
      its effect through the activation of the immune system against the target.
    is_a: immune_system_modulation
  post_transcriptional_regulation:
    text: post_transcriptional_regulation
    description: A modulation mechanism which controls expression of a target gene
      at the RNA level after a gene has been transcribed into messenger RNA (mRNA).
    is_a: modulation
  molecular_modification:
    text: molecular_modification
    description: A modulation mechanism through which an effect is mediated by the
      modification of a target, through addition of chemical moieties such phosphate
      groups, ubiquitin, lipids, etc., which alter its activity or cellular behavior.
    is_a: modulation
  phosphorylation:
    text: phosphorylation
    is_a: molecular_modification
  dephosphorylation:
    text: dephosphorylation
    is_a: molecular_modification
  neddylation:
    text: neddylation
    is_a: molecular_modification
  deneddylation:
    text: deneddylation
    is_a: molecular_modification
  lipidation:
    text: lipidation
    is_a: molecular_modification
  palmitoylation:
    text: palmitoylation
    is_a: lipidation
  myristoylation:
    text: myristoylation
    is_a: lipidation
  tyrosination:
    text: tyrosination
    is_a: molecular_modification
  carboxylation:
    text: carboxylation
    is_a: molecular_modification
  ubiquitination:
    text: ubiquitination
    is_a: molecular_modification
  monoubiquitination:
    text: monoubiquitination
    is_a: ubiquitination
  polyubiquitination:
    text: polyubiquitination
    is_a: ubiquitination
  deubiquitination:
    text: deubiquitination
    is_a: molecular_modification
  sulfation:
    text: sulfation
    is_a: molecular_modification
  reduction:
    text: reduction
    description: A molecular modification mechanism in which an effector modifies
      a target substrate via a reduction reaction.
    is_a: molecular_modification
  oxidation:
    text: oxidation
    description: A molecular modification mechanism in which an effector modifies
      a target substrate via an oxidation reaction.
    is_a: molecular_modification
  acetylation:
    text: acetylation
    is_a: molecular_modification
  deacetylation:
    text: deacetylation
    is_a: molecular_modification
  glycosylation:
    text: glycosylation
    is_a: molecular_modification
  deglycosylation:
    text: deglycosylation
    is_a: molecular_modification
  methylation:
    text: methylation
    is_a: molecular_modification
  trimethylation:
    text: trimethylation
    is_a: methylation
  demethylation:
    text: demethylation
    is_a: molecular_modification
  sumoylation:
    text: sumoylation
    is_a: molecular_modification
  desumoylation:
    text: desumoylation
    is_a: molecular_modification
  ADP-ribosylation:
    text: ADP-ribosylation
    is_a: molecular_modification
  de-ADP-ribosylation:
    text: de-ADP-ribosylation
    is_a: molecular_modification
  ampylation:
    text: ampylation
    description: A molecular modification involving the addition of an adenylyl (AMP)
      moiety to a substrate protein residue.
    is_a: molecular_modification
  hydroxylation:
    text: hydroxylation
    is_a: molecular_modification
  s_nitrosylation:
    text: s_nitrosylation
    is_a: molecular_modification

</code></pre>

</details>









  




                
              </article>
            </div>
          
          
  <script>var tabs=__md_get("__tabs");if(Array.isArray(tabs))e:for(var set of document.querySelectorAll(".tabbed-set")){var labels=set.querySelector(".tabbed-labels");for(var tab of tabs)for(var label of labels.getElementsByTagName("label"))if(label.innerText.trim()===tab){var input=document.getElementById(label.htmlFor);input.checked=!0;continue e}}</script>

<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    
      
      <script id="__config" type="application/json">{"base": "..", "features": ["content.tabs.link"], "search": "../assets/javascripts/workers/search.d50fe291.min.js", "tags": null, "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}, "version": null}</script>
    
    
      <script src="../assets/javascripts/bundle.56ea9cef.min.js"></script>
      
    
  </body>
</html>